logo
Study sees lower chances of Milky Way crashing into Andromeda galaxy

Study sees lower chances of Milky Way crashing into Andromeda galaxy

Reuters02-06-2025
WASHINGTON, June 2 (Reuters) - The Milky Way and the neighboring Andromeda galaxy are currently hurtling through space toward each other at a speed of about 250,000 miles per hour (400,000 kph), setting up a possible future galactic collision that would wreck both of them.
But how likely is this cosmic crash? While previous research forecast it to occur roughly 4-4.5 billion years from now, a new study that uses recent observational data and adds fresh variables indicates that a collision is far from certain. It puts the likelihood of a collision in the next 5 billion years at less than 2% and one in the next 10 billion years at about 50%.
Galactic mergers are not like a demolition derby, with stars and planets crashing into each other, but rather a complicated blending on an immense scale.
"The future collision - if it happens - would be the end of both the Milky Way and Andromeda," said University of Helsinki astrophysicist Till Sawala, lead author of the study published on Monday in the journal Nature Astronomy, opens new tab, with the structure of both being destroyed and a new galaxy with an elliptical shape arising from the merger.
"If a merger happens, it is more likely to occur 7-8 billion years in the future. But we find that based on the current data, we cannot predict the time of a merger, if it happens at all," Sawala said.
The two galaxies currently are around 2.5 billion light-years from each other. A light-year is the distance light travels in a year, 5.9 trillion miles (9.5 trillion km).
The potential collision is so far in the future that Earth by that time is forecast to become a completely different kind of place. Our planet is expected to be rendered uninhabitable roughly a billion years from now, with the sun becoming so hot that it will boil away our planet's oceans.
The sun is one of the Milky Way's many billions of stars. The total mass of our spiral-shaped galaxy - including its stars and interstellar gas as well as its dark matter, which is invisible material whose presence is revealed by its gravitational effects - is estimated at approximately one trillion times the mass of the sun.
The Andromeda galaxy has a shape and total mass similar to the Milky Way's.
The researchers simulated the Milky Way's movement over the next 10 billion years using updated data from the Gaia and Hubble space telescopes and various ground-based telescopes as well as revised galactic mass estimates.
Other nearby galaxies are forecast to factor into whether a collision occurs. Previous research accounted for the gravitational influence of the Triangulum galaxy, also called Messier 33 or M33, which is about half the size of the Milky Way and Andromeda, but did consider the Large Magellanic Cloud, a smaller satellite galaxy of the Milky Way, as this study does.
"We find that if only M33 is added to the two-body system, the chance of a Milky Way-Andromeda merger actually increases, but the inclusion of the Large Magellanic Cloud has the opposite effect," Sawala said.
The researchers concluded that a merger between the Milky Way and the Large Magellanic Cloud is almost certain within the next 2 billion years, long before a potential collision with Andromeda.
One noteworthy difference between the Milky Way and Andromeda is the mass of the supermassive black holes at their centers. The Milky Way's Sagittarius A*, or Sgr A*, is about 4 million times the mass of the sun. Its Andromeda counterpart is about 100 million the sun's mass.
"Collisions between stars are very unlikely, but the two supermassive black holes would sink to the center of the newly formed galaxy, where they would eventually merge," Sawala said.
Galactic mergers have occurred since the universe's early stages and are particularly common in areas of the universe where galaxies are clustered together.
"In the early universe, galaxy mergers were much more frequent, so the first mergers would have occurred very shortly after the first galaxies had formed," Sawala said.
"Minor mergers - with much smaller galaxies - happen more frequently. Indeed, the Milky Way is currently merging with several dwarf galaxies," Sawala said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Weight loss jabs like Mounjaro and Wegovy could make you go BLIND, experts warn
Weight loss jabs like Mounjaro and Wegovy could make you go BLIND, experts warn

Daily Mail​

timean hour ago

  • Daily Mail​

Weight loss jabs like Mounjaro and Wegovy could make you go BLIND, experts warn

Two of the world's most popular slimming injections may raise the risk of a sight-threatening eye disease in people with type 2 diabetes, researchers have warned. A team from Massachusetts analysed health records from more than 185,000 patients prescribed GLP-1 receptor agonist drugs—a class that includes semaglutide, the active ingredient in Wegovy, and tirzepatide, found in Mounjaro. These medications suppress appetite and are increasingly used by people with diabetes and obesity to shed pounds and control blood sugar levels. But the study found they were linked to a 'modestly increased risk' of diabetic retinopathy—a condition caused by damage to blood vessels in the retina, the light-sensitive layer at the back of the eye. Left untreated, it can lead to permanent sight loss. Even so, the researchers noted that fewer people in the study developed the most severe complications of diabetic retinopathy, such as blindness, even among those who already had the condition before starting the drugs. The analysis also found no statistically significant difference in the risk of NAION—non-arteritic anterior ischaemic optic neuropathy—a rare disorder that causes sudden vision loss in one eye when blood flow to the optic nerve is cut off. Based on their findings, the authors said people with type 2 diabetes taking the drugs should have regular eye checks to catch any problems early. The researchers behind the Massachusetts study disclosed conflicts of interest with companies that manufacture the drugs, including Eli Lilly and Novo Nordisk. Separately, another US research team—whose findings were also published today—analysed data from 159,398 people and did find an increased risk of sudden sight loss linked to the injections. They looked specifically at patients with type 2 diabetes and no history of eye problems, comparing those prescribed semaglutide or tirzepatide with a matched control group. Their results showed an increased risk of NAION—non-arteritic anterior ischaemic optic neuropathy—and other optic nerve disorders in the medicated group, although they stressed the 'overall risk was low.' After two years of follow-up, 35 patients (0.04 per cent) in the semaglutide or tirzepatide group had developed NAION, compared to 19 patients (0.02 per cent) in the control group. In addition, 93 patients (0.12 per cent) in the medicated group developed other optic nerve disorders, versus 54 patients (0.07 per cent) in the control group. The researchers added: 'No association was found with other disorders of the optic nerve or visual pathways.' In this second study, the researchers didn't disclose any conflicts of interests with weight loss jab manufacturers. The weight-loss jabs have been found to help people lose up to 20 per cent of their body weight in just a few months. However, there have been numerous reports of side effects after getting the jabs from hair loss and constipation to extreme cases of bloating. Recently, US experts found that semaglutide—may 'waste away muscles', making it harder to lose weight. And earlier this summer, in June, slimming jabs like Mounjaro and Wegovy were linked to more than 100 deaths in Britain. A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to and including May 29. But none of the fatalities, which have all been reported since the jabs were licensed for use in the UK, were proven to be caused directly by the drugs. However, the UK medicines regulator launched a probe into the safety of fat jabs after hundreds of Britons developed pancreatitis, specifically, leaving ten dead. Nevertheless, the weight loss jabs have remained popular, with pharmacists warning just last month that booming demand may become 'unsustainable'. The warning was issued by The National Pharmacy Association (NPA)—which represents over 6,000 community pharmacies. It came after their recent poll of over 2,000 people showed an increasing demand for private and NHS-backed weight loss services. The NDA poll revealed a fifth of participants had attempted to access weight loss treatments in the last year.

Commander of NASA's Apollo 13 mission Jim Lovell dies aged 97
Commander of NASA's Apollo 13 mission Jim Lovell dies aged 97

Daily Mail​

time2 hours ago

  • Daily Mail​

Commander of NASA's Apollo 13 mission Jim Lovell dies aged 97

Legendary astronaut Jim Lovell, who commanded the almost-doomed Apollo 13 lunar mission has passed away, aged 97. Lovell helped turn the 1970 failed moon mission into a success by safely returning the crew back to Earth after an oxygen tank exploded. NASA's Sean Duffy announced the commander's passing, and said the astronaut's life and work 'inspired millions of people across the decades'. Duffy said: 'Jim's character and steadfast courage helped our nation reach the moon and turned a potential tragedy into a success from which we learned an enormous amount. We mourn his passing even as we celebrate his achievements. 'From a pair of pioneering Gemini missions to the successes of Apollo, Jim helped our nation forge a historic path in space that carries us forward to upcoming Artemis missions to the moon and beyond.' Lovell was a veteran of spaceflights Gemini VII, Gemini XII, Apollo 8, and Apollo 13. The 1968 Apollo 8 crew, with Lovell, Frank Borman, and William Anders, was the first manned mission to leave Earth's orbit, and the first to fly to and circle the moon. Though they could not land on the lunar surface, their mission still put the U.S. ahead of the Soviets in the space race. Letter writers said the crew's historic 'pale blue dot' photo of Earth from the moon, a world first, and their Christmas Eve reading from the Bible's Genesis helped lift America during the turbulent year. Tom Hanks played Lovell in director Ron Howard's acclaimed 1995 film Apollo 13. The movie was inspired by Lovell's 1994 book Lost Moon: The Perilous Voyage Of Apollo 13. Lovell recalled a meeting with Howard, in which the director asked him which actor he would want to play him. Lovell added: 'I said, Kevin Costner and Hanks never lets me forget that... But Hanks did a great job.' Lovell made a cameo appearance in the film as the commander of the U.S. Navy ship that retrieves the astronauts and shakes hands with Hanks. Lovell, who had a moon crater named in his honor, retired as an astronaut in 1973, working first for a harbor towing company and then in telecommunications. He had four children with his wife Marilyn, who died in 2023.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store